BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19841557)

  • 1. Preliminary results of SIB-IMRT in head and neck cancers: report from a regional cancer center in northern India.
    Chakraborty S; Ghoshal S; Patil VM; Oinam AS; Sharma SC
    J Cancer Res Ther; 2009; 5(3):165-72. PubMed ID: 19841557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute toxicities experienced during simultaneous integrated boost intensity-modulated radiotherapy in head and neck cancers--experience from a north Indian regional cancer centre.
    Chakraborty S; Ghoshal S; Patil V; Oinam A; Suresh S
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):676-86. PubMed ID: 19748768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients.
    Studer G; Huguenin PU; Davis JB; Kunz G; Lütolf UM; Glanzmann C
    Radiat Oncol; 2006 Mar; 1():7. PubMed ID: 16722599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
    Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
    Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
    Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
    Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
    Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
    Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
    Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
    Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial clinical experience with helical tomotherapy for head and neck cancer.
    Chen AM; Jennelle RL; Sreeraman R; Yang CC; Liu T; Vijayakumar S; Purdy JA
    Head Neck; 2009 Dec; 31(12):1571-8. PubMed ID: 19405087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations.
    Guerrero M; Li XA; Ma L; Linder J; Deyoung C; Erickson B
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):933-9. PubMed ID: 15936580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer.
    Nuyts S; Dirix P; Hermans R; Poorten VV; Delaere P; Weltens C; Van den Bogaert W
    Head Neck; 2007 Aug; 29(8):720-30. PubMed ID: 17315171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review.
    Orlandi E; Palazzi M; Pignoli E; Fallai C; Giostra A; Olmi P
    Crit Rev Oncol Hematol; 2010 Feb; 73(2):111-25. PubMed ID: 19409808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
    Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R
    Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated radiotherapy with simultaneous integrated boost fractionation and intensity-modulated radiotherapy for advanced head and neck cancer.
    Schwartz M; Vuong T; Ballivy O; Parker W; Patrocinio H
    Otolaryngol Head Neck Surg; 2007 Apr; 136(4):549-55. PubMed ID: 17418249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.
    Ghoshal S; Goda JS; Mallick I; Kehwar TS; Sharma SC
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.